Cargando…
Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis
Chemotherapy-induced peripheral neuropathy (CIPN) is the most common neurologic complication of chemotherapy, resulting in symptoms like pain, sensory loss, and numbness in the hands and feet that cause lots of uneasiness in patients with cancer. They often suffer from pain so severe that it interru...
Autores principales: | Spera, Maria C., Cesta, Maria C., Zippoli, Mara, Varrassi, Giustino, Allegretti, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469051/ https://www.ncbi.nlm.nih.gov/pubmed/36098939 http://dx.doi.org/10.1007/s40122-022-00431-8 |
Ejemplares similares
-
Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives
por: Giorgio, Cristina, et al.
Publicado: (2021) -
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
por: Han, Yaqin, et al.
Publicado: (2013) -
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
por: Canta, Annalisa, et al.
Publicado: (2015) -
An asymptomatic mutation complicating severe chemotherapy-induced peripheral neuropathy (CIPN): a case for personalised medicine and a zebrafish model of CIPN
por: Holloway, Michael P, et al.
Publicado: (2016) -
Prevention and Treatment for Chemotherapy-Induced Peripheral
Neuropathy: Therapies Based on CIPN Mechanisms
por: Hu, Lang-Yue, et al.
Publicado: (2019)